Type 1 diabetes mellitus (T1DM) is one of the important causes of chronic kidney disease
(CKD) and end-stage renal failure (ESRF). Even with the best available treatment options …

The incidence of diabetes mellitus (DM) is steadily increasing annually, with 537 million
diabetic patients as of 2021. Restoring diminished β cell mass or impaired islet function is …

Islet transplantation improves metabolic control in patients with unstable type 1 diabetes.
Clinical outcomes have been improving over the last decade, and the widely used beta …

Islet transplantation represents a promising therapeutic approach for diabetes management,
yet the isolation and evaluation of pancreatic islets remain challenging. This study focuses …

Over the past few years, we have witnessed many advances in the understanding of
diabetes and its management. Greater insight into pathogenesis has led to the approval of …

Introduction Stem cells from various sources including major salivary glands have been
used to establish pancreatic differentiation in an attempt to provide new treatment options for …

Pancreatic transplantation is considered by the American Diabetes Association and the
European Association for the Study of Diabetes an acceptable surgical procedure in patients …

This comprehensive review addresses the global health challenge of disparities in pancreas
transplant access, particularly in low-and middle-income countries (LMICs) compared to …

According to the most recent data,~ 463 million adults are living with diabetes mellitus (DM),
of whom~ 10% suffer from type 1 DM. 1 The prevalence of DM in the USA in 2018 was …

本研究系统剖析了胰腺移植预后的关键决定因素及常见术后并发症. 我们通过综合分析糖尿病
类型, 性别匹配, 受体身体质量指数(body mass index, BMI), 热缺血时间, 灌洗液类型以及手术 …